Camson Bio Technologies Limited reported audited standalone earnings results for the fourth quarter and year ended March 31, 2016 and audited consolidated earnings results for the year ended March 31, 2016. For the quarter, on standalone basis, negative net sales/income from operation was INR 56.345 million against net sales/income from operation of INR 374.969 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 280.427 million against loss from operation before other income, finance cost and exceptional item of INR 65.577 million a year ago. Loss from ordinary activities before tax was INR 297.911 million against loss from ordinary activities before tax of INR 22.859 million a year ago. Net loss was INR 270.151 million or INR 9.01 per diluted share against net loss of INR 31.447 million or INR 1.10 per diluted share a year ago. For the year, on standalone basis, net sales/income from operation was INR 254.033 million against INR 1,693.815 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 360.963 million against profit from operation before other income, finance cost and exceptional item of INR 26.520 million a year ago. Loss from ordinary activities before tax was INR 399.278 million against profit from ordinary activities before tax of INR 50.479 million a year ago. Net loss was INR 378.348 million or INR 12.61 per diluted share against net profit of INR 30.823 million or INR 1.07 per diluted share a year ago. For the year, on consolidated basis, net sales/income from operation was INR 621.153 million against INR 2,030.202 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 380.908 million against profit from operation before other income, finance cost and exceptional item of INR 6.142 million a year ago. Loss from ordinary activities before tax was INR 435.104 million against profit from ordinary activities before tax of INR 20.908 million a year ago. Net loss was INR 414.226 million or INR 1.07 per diluted share against net profit of INR 1.121 million or INR 0.67 per diluted share a year ago.